Insight

Varadha Balaji Venkadakrishnan: Lineage-specific activity of EZH2 in advanced Prostate Cancer

Photo from Varadha Balaji Venkadakrishnan/X

Aug 12, 2024, 22:05

Varadha Balaji Venkadakrishnan: Lineage-specific activity of EZH2 in advanced Prostate Cancer

Varadha Balaji Venkadakrishnan, Postdoctoral Researcher at Dana-Farber Cancer Institute, shared on X about a recent paper titled “Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes” published in Nature Communications.

Authors: Varadha Balaji Venkadakrishnan et al.

specific activity

“Check out our paper on lineage-specific activity of EZH2 in advanced Prostate Cancer subtypes published in Nature Communications.

Thank you Misha Beltran for strong support!”

specific activity

Source: Varadha Balaji Venkadakrishnan/X

Adam Presser cancer Dana-Farber Cancer Institute David Rickman EZH2 Himisha Beltran Misha Beltran Myles Brown National Cancer Center Nature Communications OncoDaily Oncology PCF Science prostate cancer Richa Singh Varadha Balaji Venkadakrishnan

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage